Skip to main content
NCBI home page
BMC Chemistry logoLink to BMC Chemistry
. 2020 Aug 14;14(1):51. doi: 10.1186/s13065-020-00701-6

Antibacterial activity of Cu(II) and Co(II) porphyrins: role of ligand modification

Belete B Beyene 1,✉, Getaneh A Wassie 1
PMCID: PMC7427740  PMID: 32818202

Abstract

In this study, we report antibacterial activity of metalloporphyrins; 5, 10, 15, 20-tetrakis (para-X phenyl)porphyrinato M (II) [where X = H, NH2 and COOMe for M = Cu and X = COOH  and OMe for M = Co]. The activity study of the as-synthesized metalloporphyrins toward two Gram-positive (S. aureus and S. pyogenes) and two Gram-negative (E. coli and K. pneumoniae) bacteria showed a promising inhibitory activity. Among the complexes under study, the highest antibacterial activity is observed for 5, 10, 15, 20-tetrakis (p-carboxyphenyl)porphyrinato cobalt (II), with inhibition zone of 16.5 mm against Staphylococcus aureus (S. aureus). This activity could be attributed to the high binding ability of COOH group to cellular components, membranes, proteins, and DNA as well as the lipophilicity of the complex. Moreover, consistent with literature report, the study revealed that metalloporphyrins with electron withdrawing group at para-positions have better antibacterial activity than metalloporphyrin which possess electron donating group at para position.

Keywords: Cobalt porphyrin, Inhibition, Copper porphyrin, Antibacterial activity, Lipophilicity

Introduction

Metalloporphyrins are assumed to have extra ordinary importance in recent years as agents for photodynamic therapy, optoelectronic devices, sensors, molecular logic devices and artificial solar energy harvesting and storage schemes [1]. Taking into account a great number of infections resulting from different bacterial species and the growing antibacterial resistance, the development of compounds with high antibacterial activities and novel mechanism of action is an urgent need [2–4]. As a consequence, researchers are designing novel, convenient, robust and inexpensive strategies for combating microorganisms with minimal invasive consequences [5, 6]. In this regard, natural and synthetic metalloporphyrins are among relatively low toxic molecules (either in vitro or in vivo) and are capable of effecting microbial and viral pathogens through the large number of different mechanisms [7]. In addition, the possibility of structural modifications place these molecules into a group of compounds that present a sustainable source for discovery of novel procedures, materials and agents active against a wide range of pathogenic microorganisms [7]. Modification of porphyrin ligand at the peripheral positions provokes tunable shape, size and symmetry which have suitable applications in materials and therapeutics [8]. The most common structural modification of synthetic porphyrins is made at the meso-position to achieve target molecules with required properties in biomedical applications such as photo diagnosis, cancer therapy and as antibacterial agents [9, 10]. Nowadays, an ever increase in the mortality rate throughout the world is linked with infectious diseases with multiple resistances to antibiotics and the lack of effective treatments [2–4].

Porphyrin based systems have been reported as potential antibacterial agents against Gram-positive and Gram-negative bacteria species for decades [11–21]. They were used to treat different kinds of bacteria including bacillus subtilis, Escherichia coli, mycobacterium smegmatis, and actinobacillus [22–24]. The activities are based on their ability to catalyse peroxidase–oxidase reactions, generate reactive oxygen species (ROS) by absorbing light and partition into lipids of bacterial membranes [2, 25]. However, in most cases, much attention has been paid to ionic porphyrins (cationic [4, 15, 16, 26–33] and anionic [34–36] presumably because of their ability to strongly bind with cellular components and better activity than the neutral ones [15, 28, 37]. But, ionic porphyrins are very limited and studies involving neutral porphyrins to treat bacterial infections are becoming attractive. In line with this, antibacterial activity has been reported against Staphylococcus aureus, Mycobacterium smegmatis and Yersinia enterocolitica by using neutral porphyrins with the alkyl substituents at the β-pyrrolic positions [15, 33, 38]. However, there is no intensive report or documantation regarding neutral porphyrins for treating antibacterial infections.

In this work we, therefore report antibacterial activity of 5, 10, 15, 20-tetrakis (para-X phenyl)porphyrinato M (II) [where X = H, NH2 and COOMe for M = Cu and X = COOH and OMe for M = Co] for the first time (Fig. 1). To the best of our knowledge the antibacterial activity of these particular metalloporphyrins is not reported previously. The study revealed the highest antibacterial activity for Co (II) porphyrin containing COOH, which could be attributed to the high binding ability of COOH group to various cellular components and its lipohilicity.

Fig. 1.

Fig. 1

Open in a new tab

A schematic diagram for bacterial growth inhibition by metalloporphyrins

Experimental

Antibacterial activity testing

The metal salts, ligands and their metal complexes were evaluated for in vitro antibacterial activities against strains of the two Gram-negative bacterial strains such as Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae); two Gram positive bacterial strains such as Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) bacterium by disc diffusion method. In this method, activity of the test compounds was expressed by measuring the diameter of zone of inhibition. The plates were observed for zones of inhibition after 24 h, and incubation at 37 °C. The diameters of the zone of inhibition produced by the complexes were compared with a standard antibiotic drug Gentamycin. All the bacterial strains used in the experiment were received from microbiology laboratory, Bahir Dar University.

Media preparation and sterilization

The Culture media (Mueller Hinton) were prepared according to the manufacturer’s guideline (suspend 38 g in 1 L of distilled water). The mass of the culture medium was weighed and dissolved in distilled water. The mixture was stirred with a sterilized glass rod and tightly covered with an aluminum foil and then the culture medium was autoclaved for 15 min at 121 °C. Next to that,the agar was allowed to cool in order to maintain the media in a molten stage. Petri dishes were dried in lower humidity by keeping them in a laminar flow hood. The freshly prepared and cooled Muller–Hinton agar was spread at the surface of petri dishes.

Inoculation of test plates

A small volume, about 0.1 mL of the bacterial suspensions were inoculated onto the dried surface of Muller–Hinton agar plate and streaked (swabbed) by the sterile cotton swab over the entire sterile agar surface. This procedure was repeated by streaking two more times, rotating the plate approximately 60 °C each times to ensure an even distribution of inoculums and the rim of the agar was swabbed. The lid was left ajar for 3–15 min, to allow for any excess surface moisture to be absorbed before applying the samples on the respective well.

Sample injection and incubation

Anti-bactericidal activities of each reagents and synthesized complexes were evaluated by the disc diffusion method. Agar were prepared by using a sterilized cork borer with 6 mm diameter, 4 mm deep and about 2.5 cm apart to minimize overlapping of zones. Then holes of 6 mm diameter were punched carefully using a sterile cork borer. The metal salts of each complex, DMSO, the ligands, and their metal complexes were carefully injected to the respective disc in duplicate. The reference antibiotic agent disc (gentamycin) was dispensed via sterile pair of forceps onto the surface of the inoculated agar plate and pressed down to ensure complete contact with the agar surface. It was allowed to diffuse for about 40 min before incubation and then the plates were incubated at 37 °C for 24 h. After 24 h incubation, the antibacterial activity was evaluated by measuring the diameter of inhibition zones in millimeter. The test was carried out in duplicate and the results were recorded as mean ± standard deviation.

Results and discussion

Synthesis and photophysical properties

The metalloporphyrins employed in this study were synthesized by following reported methods [39–44]. The detail synthetic procedure, characterization data and photophysical properties of as synthesized compounds is shown in supporting information.

Antibacterial activity

The as synthesized metalloporphyrins were tested for their in vitro antibacterial activity in the open condition under visible/white light and the results were compared with the ligand, metal salt and the commercially available drug, gentamycin,. The activity is 1st tested against two Gram-positive (Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) and two Gram-negative [Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae)] bacteria by using 31.25, 62.5, 125, 250 and 500 mg/L of each metalloporphyrins. All the tested metalloporphyrins were found to be active against all the tested pathogens and compared with the commercially available antibiotic drug (gentamycin). The result of antibacterial activities is reported as inhibition zone diameter (mm) for the concentration of 500 mg/L as shown in Table 1.

Table 1.

Antibacterial activiy (mean IZ diameter (mm) ± SD) of metalloporphyrins, corresponding ligands, metal salts, and gentamycin with concentration 500 mg/L

Compounds Antibacterial activiy (mean IZ diameter (mm) ± SD)
S. aureus S. pyogenes E. coli K. pneumonia
CoTPPCOOH 16.5 ± 0.5 15 ± 0.3 16 ± 0.5 16 ± 0.6
CoTPPOMe 12 ± 0.2 14 ± 0.6 10 ± 0.3 12 ± 02
CuTPPCOOMe 16 ± 0.2 15 ± 0.5 13 ± 0.6 13.5 ± 075
CuTPPNH2 13 ± 0.4 13.5 ± 0.3 12 ± 0.45 12.5 ± 0.6
H2TPPCOOH 8.5 ± 0.2 9 ± 0.3 7.5 ± 0. 3 7.5 ± 0.4
H2TPPCOOMe 8.25 ± 0.3 8 ± 0.2 7.5 ± 0.03 7.5 ± 0.2
H2TPPOMe 7 ± 0.3 7.25 ± 0.3 7 ± 0.3 7 ± 0.2
H2TPPNH2 7.5 ± 0.2 7.75 ± 0.3 7 ± 0.01 7 ± 0.2
CuCl2·2H2O 6.75 ± 0.2 7 ± 0.3 6.25 ± 0.02 6.5 ± 0.4
Co acetate 6.5 ± 0.1 7 ± 0.2 6.5 ± 0.1 6.5 ± 0.2
DMSO 0 ± 0.00 0 ± 0.00 0 ± 0.00 0 ± 0.00
10 µg gentamicin 25 ± 0.6 27 ± 0.75 26 ± 0.75 25 ± 0.5
Open in a new tab

All the complexes under study showed better antibacterial growth inhibition activity than the corresponding porphyrin ligand. This is a clear indication for the involvement of metal ions as potential candidates in bacterial growth inhibition. The justification for enormous antibacterial activity of transition metal complexes of porphyrins is based on overtone concept and chelation theory. The solubility of the complexes in lipid is an important factor to control the antibacterial activity [45–48]. Based on the overtone concept of cell permeability, the passage of the materials which are only lipophilic is favored by the lipid membrane that surrounds the cell. On the other hand, the dramatic decrease in polarity of metal ions because of an overlap of orbital of ligand and partial sharing of the positive charge of the metal ion with donor groups can be blearily explained by employing chelation theory. Moreover, this phenomenon increases the π-electron delocalization all over the whole porprhyrin ring and enhances the lipid solubility behavior of the complexes. Presumably, an increase in lipid-solubility of the porphyrin ligands upon metallation makes the complexes easily move across the bacterial cell. This process inhibits the metals to bind with the enzymes in microorganisms. In addition, the respiration process of the cell could be interrupted and thereby block the synthesis of biomolecules, which limit over enlargement of organism [49].

As can be seen from Table 2 and Fig. 2 increasing the concentration of antibacterial agents increase the activity very slightly and metalooporphyrins under study are active and inhibit bacteria even at the lowest concentration (31.25 mg/L). Moreover, the bacteria growth inhibition activity of the complexes is not significantly different among different bacteria species. The 5, 10, 15, 20-tetrakis (p-carboxyphenyl)porphyrinato cobalt (II), exhibited the greater antimicrobial activities than other metalloporphyrins with inhibition zones 16.5 mm for S. aureus presumably attributing to its ability to strongly bind with cellular components.

Table 2.

Antibacterial activiy (mean IZ diameter (mm) ± SD) of cobaltporphyrins, at different concentrations

Cobalt complexes at different concentration Antibacterial activiy (mean IZ diameter (mm) ± SD)
S. aureus S. pyogenes E. coli K. pneumonia
500 mg/L
 CoTPPCOOH 16.5 ± 0.5 15 ± 0.3 16 ± 0.5 16 ± 0.6
 CoTPPOMe 12 ± 0.2 14 ± 0.6 10 ± 0.3 12 ± 02
250 mg/L
 CoTPPCOOH 12.5 ± 0.45 13 ± 0.3 13 ± 0.4 13 ± 0.3
 CoTPPOMe 11.5 ± 0.3 10 ± 0.2 11.5 ± 0.2 11 ± 0.0.45
125 mg/L
 CoTPPCOOH 13 ± 0.3 11 ± 0.55 11 ± 0.3 11 ± 0.75
 CoTPPOMe 10.5 ± 0.5 9 ± 0.5 10 ± 0.5 9 ± 0.3
62.5 mg/L
 CoTPPCOOH 12 ± 0.6 10.5 ± 0.4 12 ± 0.5 12 ± 0.4
 CoTPPOMe 8 ± 0.2 8 ± 0.3 9 ± 0.4 9.5 ± 0.2
31.25 mg/L
 CoTPPCOOH 10.5 ± 0.3 10 ± 0.2 9 ± 0.1 9.5 ± 0.3
 CoTPPOMe 8 ± 0.4 8 ± 0.2 8 ± 0.45 9 ± 0.3
Open in a new tab

Fig. 2.

Fig. 2

Open in a new tab

Bar graph of 5, 10, 15, 20-tetrakis (p-X phenyl)porphyrinato cobalt (II), where X = COOH and OMe on the same concentration pattern

For copper complexes of 5, 10, 15, 20-tetrakis (p-X phenyl)porphyrin, as the concentration of the complexes increase, the antimicrobial activity also increase as shown in Table 3 (Figs. 3, 4).

Table 3.

Antibacterial activity (mean IZ diameter (mm) ± SD) of copperporphyrins, at different concentrations

Copper complexes at different concentration Antibacterial activity (mean IZ diameter (mm) ± SD)
S. aureus S. pyogenes E. coli K. pneumonia
500 mg/L
 CuTPPCOOMe 16 ± 0.2 15 ± 0.5 13 ± 0.6 13.5 ± 075
 CuTPPNH2 13 ± 0.4 13.5 ± 0.3 12 ± 0.45 12.5 ± 0.6
250 mg/L
 CuTPPCOOMe 12 ± 0.45 12.5 ± 0.3 12 ± 0.02 11.5 ± 0.3
 CuTPPNH2 11 ± 0.2 11 ± 0.6 10.5 ± 0.3 10 ± 0.2
125 mg/L
 CuTPPCOOMe 11.5 ± 0.5 11 ± 0.45 9.5 ± 0.02 10 ± 0.5
 CuTPPNH2 10 ± 0.75 11.5 ± 0.4 9 ± 0.3 9.5 ± 0.4
62.5 mg/L
 CuTPPCOOMe 10.5 ± 0.2 10.25 ± 0.5 9 ± 0.03 9.5 ± 0.2
 CuTPPNH2 9 ± 0.5 8.5 ± 0.5 9 ± 0.2 8.5 ± 0.45
31.25 mg/L
 CuTPPCOOMe 9 ± 0.4 8.75 ± 0.3 8.5 ± 0.04 8 ± 0.2
 CuTPPNH2 8 ± 0.2 8 ± 0.1 7.5 ± 0.5 8 ± 0.75
Open in a new tab

Fig. 3.

Fig. 3

Open in a new tab

Inhibition of; a Staphylococcus aureus (S. aureus) and b Streptococcus pyogenes (S. pyogenes) by 5, 10, 15, 20-tetrakis (p-carboxyphenyl)porphyrinato cobalt (II)

Fig. 4.

Fig. 4

Open in a new tab

Inhibition of; a Escherichia coli (E. coli) and b Klebsiella pneumoniae (K. pneumoniae) by 5, 10, 15, 20-tetrakis (p-carboxyphenyl)porphyrinato cobalt (II)

Though antimicrobial activity of porphyrin derivatives of natural origin with COOH groups at β-pyrrolic positions have been reported so far [50–57], metalloporpyhrins with p-COOH at meso position of phenyl ring is not reported. Moreover, consistent with the report by Ke and coworkers, the electron withdrawing substituents enhance antibacterial activity attributing to increasing lipophilicity and polarity of the complex [15, 28]. Generally, the metal complexes containing electron withdrawal groups (with COOH and –COOMe showed better activities than the metal complex containing electron donating groups namely –NH2 and –OMe.

Conclusion

In general, antibacterial activity of metalloprphyrins with different peripheral substituents is reported. The study indicated that all the complexes under study have promising antibacterial activity toward two Gram-positive (Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) and two Gram-negative [Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae)] bacterial species. It is also found that bacterial growth inhibition by metallopophyrins is higher than the corresponding metal salt or DMSO. Increasing the concentration of the complexes slightly increases the inhibition activity. Among the complexes under study, the highest antibacterial activity is observed for CoTPPCOOH, which could be attributed to the high binding ability of COOH group to cellular components, membranes, proteins, and DNA as well as the lipohilicity of the complex. Moreover, consistent with literature report, the study revealed that metalloporphyrins with electron withdrawing group at para-positions have better antibacterial activity than metalloporphyrins which possess electron donating group at para position. The result finally concludes that metalloporphyrin derivatives are promising candidates for antibacterial activity.

Acknowledgements

We would like to acknowledge department of chemistry, Bahir Dar University for providing laboratory space and chemicals to do our experiment. Moreover, we are pleased to thank Institute of Chemistry Academia Sinica to help us run ESI-Mass and NMR experiments. We are also grateful department of microbiology for allowing us to conduct antibacterial activity.

Abbreviations

DNA

Deoxyribonucleic acid

TPP

Tetra phenyl porphyrin

M (II)

Metal with oxidation state of 2

Me

Methyl

OMe

Methoxy

COOMe

Methoxycarbonyl

ROS

Reactive oxygen species

°C

Degree centigrade

h

Hour

DMSO

Dimethylsulphoxide

IZ

Inhibition zone

SD

Standard Deviation

S. aureus

Staphylococcus aureus

S. pyogenes

Streptococcus pyogenes

E. coli

Escherichia coli

K. pneumoniae

Klebsiella pneumonia

g

Gram

mg

Milligram

L

Liter

mL

Milliliter

µg

Microgram

mm

Millimeter

Authors' contributions

BBB synthesized the ligands, analyzed and interpreted the spectroscopic and Mass data, organized data and completed write-up of the manuscript. GAW performed the synthesis of metalloporphyrin part and did manuscript drafting. All authors read and approved the final manuscript.

Funding

No financial support for this project. But Bahir Dar University provides only chemicals and facilities for our research.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

All data generated or analyzed during this study are included in this manuscript and its supplementary information files.

Competing interests

We declare that no any competing interest.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Kadish KM, Smith KM, Guilard R. Applications: past, present and future. The porphyrin handbook, vol 6. San Diego: Academic Press; 2000. [Google Scholar]
  • 2.Spagnul C, Turner LC, Greenman FJ, Boyle RW. Synthesis and bactericidal properties of porphyrins immobilized in a polyacrylamide support: influence of metal complexation on photoactivity. J Mater Chem B. 2017;5:1834. doi: 10.1039/C6TB03198F. [DOI] [PubMed] [Google Scholar]
  • 3.Ramanan L, Adriano D, Chand W, Anita KMZ, Heiman FLW, Nithima S, Erika V, Gabriel LH, Ian MG, Herman G, Christina G, Anthony DS, Maryam B, Göran T, Will W, Eva O, Arturo QP, Farah NQ, Fatima M, Sam K, Zulfiqar AB, Anthony C, Richard B, Gerard DW, Eric DB, Otto C. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098. doi: 10.1016/S1473-3099(13)70318-9. [DOI] [PubMed] [Google Scholar]
  • 4.Mondal D, Bera S. Porphyrins and phthalocyanines: promising molecules for light-triggered antibacterial nanoparticles. Adv Nat Sci Nanosci Nanotechnol. 2014;5:033002. doi: 10.1088/2043-6262/5/3/033002. [DOI] [Google Scholar]
  • 5.Gholamreza K, Saeed K, Asghar N. New aminoporphyrins bearing urea derivative substituents: synthesis, characterization, antibacterial and antifungal activity. Braz Arch Biol Technol. 2015;58(3):431–442. doi: 10.1590/S1516-8913201500024. [DOI] [Google Scholar]
  • 6.Alenezi K, Tovmasyan A, Batinic-Haberle I, Benov LT. Optimizing Zn porphyrin-based photosensitizers for efficient antibacterial photodynamic therapy. Photodiagn Photodyn Ther. 2017;17:154–159. doi: 10.1016/j.pdpdt.2016.11.009. [DOI] [PubMed] [Google Scholar]
  • 7.Amarnath V, Kranthi KG, Patri SV. Synthesis of novel porphyrin-based lipids and their antibacterial activity. Med Chem Res. 2011;20:1068–1073. doi: 10.1007/s00044-010-9432-0. [DOI] [Google Scholar]
  • 8.Kadish KM, Smith KM, Guilard R. The porphyrin handbook. Burlington: Academic Press; 1999. [Google Scholar]
  • 9.Alexandra BO, Harold SF. Effects of substituents on the photophysical properties of symmetrical porphyrins. Dyes Pigm. 2013;96:440–448. doi: 10.1016/j.dyepig.2012.09.011. [DOI] [Google Scholar]
  • 10.Gauri DB, Sujata K, Madhulika B, Deepmala G, Ashu K, Geeta D. Synthesis and spectroscopic and biological activities of Zn(II) porphyrin with oxygen donors. Bioinorg Chem Appl. 2014;782762:1–14. doi: 10.1155/2014/782762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lindsey JS, Kadish KM, Smith KM, Guilard R. Applications: past present and future the porphyrin handbook. San Diego: Academic Press; 2000. p. 1. [Google Scholar]
  • 12.Kasturi C, Platz MS. Inactivation of lambda phage with 658 nm light using a DNA binding porphyrin sensitizer. Photochem Photobiol. 1992;56:427. doi: 10.1111/j.1751-1097.1992.tb02184.x. [DOI] [PubMed] [Google Scholar]
  • 13.Casteel MJ, Jayaraj K, Gold A, Ball LM, Sobsey MD. Photoinactivation of hepatitis a virus by synthetic porphyrins. Photochem Photobiol. 2004;80:294. doi: 10.1562/2004-04-05-RA-134.1. [DOI] [PubMed] [Google Scholar]
  • 14.Nitzan Y, Ashkenazi H. Photoinactivation of acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Curr Microbiol. 2001;42:408. doi: 10.1007/s002840010238. [DOI] [PubMed] [Google Scholar]
  • 15.Banfi S, Caruso E, Buccafurni L, Battini V, Zazzaron S, Barbieri P, Orlandi V. Antibacterial activity of tetraaryl-porphyrin photosensitizers: an in vitro study on gram negative and gram positive bacteria. J Photochem Photobiol. 2006;85:28. doi: 10.1016/j.jphotobiol.2006.04.003. [DOI] [PubMed] [Google Scholar]
  • 16.NitzanY Dror R, Ladan H, Malik Z, Kimel S, Gottfried V. Structure-activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol. 1995;62:342. doi: 10.1111/j.1751-1097.1995.tb05279.x. [DOI] [PubMed] [Google Scholar]
  • 17.Benov L, Batinic-Haberle I, Spasojevic I, Fridovich I. Isomeric N-alkylpyridylporphyrins and their Zn(II) complexes: inactive as SOD mimics but powerful photosensitizers. Arch Biochem Biophys. 2002;402:159. doi: 10.1016/S0003-9861(02)00062-0. [DOI] [PubMed] [Google Scholar]
  • 18.Oliveira A, Almeida A, CarvalhoToméFaustinoNeves CMJPMAMGAC, Tomé, Cavaleiro JA, Cunha A. Porphyrin derivatives as photosensitizers for the inactivation of bacillus cereus endospores. J Appl Microbiol. 2009;106:1986. doi: 10.1111/j.1365-2672.2009.04168.x. [DOI] [PubMed] [Google Scholar]
  • 19.Cormick MP, Alvarez MG, Rovera M, Durantini EN. Photodynamic inactivation of candida albicans sensitized by tri- and tetra-cationic porphyrin derivatives. Eur J Med Chem. 2009;44:1592. doi: 10.1016/j.ejmech.2008.07.026. [DOI] [PubMed] [Google Scholar]
  • 20.Nitzan Y, Balzam-Sudakevitz A, Ashkenazi H. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J Photochem Photobiol. 1998;42:211. doi: 10.1016/S1011-1344(98)00073-6. [DOI] [PubMed] [Google Scholar]
  • 21.Nitzan Y, Ashkenazi H. Photoinactivation of Deinococcus radiodurans: an unusual gram-positive microorganism. Photochem Photobiol. 1999;69:505. doi: 10.1111/j.1751-1097.1999.tb03320.x. [DOI] [Google Scholar]
  • 22.Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997;8:23. doi: 10.1016/S0924-8579(96)00353-6. [DOI] [PubMed] [Google Scholar]
  • 23.Ashkenazi H, Nitzan Y, Gal D. Photodynamic effects of antioxidant substituted porphyrin photosensitizers on gram-positive and -negative bacterial. Photochem Photobiol. 2003;77:186. doi: 10.1562/0031-8655(2003)077<0186:PEOASP>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 24.Kreitner M, Wagner KH, Alth G, Ebermann R, Foissy H, Elmadfa I. Haematoporphyrin- and sodium chlorophyllin-induced phototoxicity towards bacteria and yeasts—a new approach for safe foods. Food Control. 2001;12:529. doi: 10.1016/S0956-7135(01)00057-3. [DOI] [Google Scholar]
  • 25.DeRosa MC, Crutchley RJ. Photosensitized singlet oxygen and its applications. Coord Chem Rev. 2002;233–234:351–371. doi: 10.1016/S0010-8545(02)00034-6. [DOI] [Google Scholar]
  • 26.Magaraggia M, Faccenda F, Gandolfi A, Jori G. Treatment of microbiologically polluted aquaculture waters by a novel photochemical technique of potentially low environmental impact. J Environ Monitor. 2006;8:923. doi: 10.1039/b606975d. [DOI] [PubMed] [Google Scholar]
  • 27.Vzorov AN, Dixon DW, Trommel JS, Marzilli LG, Compans RW. Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob Agents Chemother. 2002;46:3917. doi: 10.1128/AAC.46.12.3917-3925.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ke GY, Dong HL, Cheng HZ, Jun LD. Study on the synthesis and antimicrobial activity of novel cationic porphyrins. Chin Chem Lett. 2009;20(4):411. doi: 10.1016/j.cclet.2008.11.030. [DOI] [Google Scholar]
  • 29.Fatemeh F, Rahmatollah R, Mehdi R. Photo-bactericidal property and characterization of cellulosic fabric treated with two tetra-cationic porphyrin compounds. J Antimicrob Agents. 2016;2:4. [Google Scholar]
  • 30.Tatyana OP, Boris NG, Oksana YZ, Maria YR, Vladimir AI, Zinaida IZ, Sergey VV, Yuriy VI. The antimicrobial properties of new synthetic porphyrins. J Porphyrins Phthalocyanines. 2003;7:755–760. doi: 10.1142/S1088424603000926. [DOI] [Google Scholar]
  • 31.Anabela T, Carla MBC, Maria AF, Maria GP, Neves MS, João PCT, Augusto CT, José ASC, Ângela C, Newton CMG, Eliana A, Adelaide A. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar Drugs. 2010;8:91–105. doi: 10.3390/md8010091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Amarnath V, Kranthi KG, Srilakshmi PV. Synthesis of novel porphyrin-based lipids and their antibacterial activity. Med Chem Res. 2011;20:1068–1073. doi: 10.1007/s00044-010-9432-0. [DOI] [Google Scholar]
  • 33.Carla MBC, João PCT, Maria AFF, Maria GPMSN, Augusto CT, José ASC, Liliana C, Eliana A, Anabela O, Ângela C, Adelaide A. Antimicrobial photodynamic activity of porphyrin derivatives: potential application medical and water disinfection. J Porphyrins Phthalocyanines. 2009;13:574–577. doi: 10.1142/S1088424609000528. [DOI] [Google Scholar]
  • 34.Adela H, Katerina B, Katerina T, Klara P, Jakub M, Svatopluk B, Robert B, Katerina L, Milan K, Jiri M, Hana K. The application of antimicrobial photodynamic therapy on S. aureus and E. coli using porphyrin photosensitizers bound to cyclodextrin. Microbiol Res. 2014;169(2–3):163–170. doi: 10.1016/j.micres.2013.07.005. [DOI] [PubMed] [Google Scholar]
  • 35.Nitzan Y, Dror R, Ladan H, Malik Z, Kimel S, Gottfried V. Structure activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol. 1995;62:342. doi: 10.1111/j.1751-1097.1995.tb05279.x. [DOI] [PubMed] [Google Scholar]
  • 36.Caminos DA, Durantini EN. Interaction and photodynamic activity of cationic porphyrin derivatives bearing different patterns of charge distribution with GMP and DNA. J Photochem Photobiol A Chem. 2008;198:274. doi: 10.1016/j.jphotochem.2008.04.005. [DOI] [Google Scholar]
  • 37.Jiangye Z, Xiaojun W, Xiaoping C, Fan Y, Jiangfeng W, Xiang Z, Xiaolian Z. Synthesis and antibacterial study of 10, 15, 20-triphenyl-5-(4-hydroxy-3-(trimethylammonium)methyl)phenylporphyrin as models for combination of porphyrin and alkylating agent. Bioorg Med Chem Lett. 2003;13(6):1097–1100. doi: 10.1016/S0960-894X(03)00053-2. [DOI] [PubMed] [Google Scholar]
  • 38.Stojiljkovic I, Kumar V, Srinivasan N. Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol Microbiol. 1999;31:429. doi: 10.1046/j.1365-2958.1999.01175.x. [DOI] [PubMed] [Google Scholar]
  • 39.Adler AD, Longo FR, Finarelli JD, Goldmacher J, Assour J, Korsakoff L. A simplified synthesis for meso-tetraphenylporphine. J Org Chem. 1967;32:476. doi: 10.1021/jo01288a053. [DOI] [Google Scholar]
  • 40.Cheng K-L, Li H-W, Ng DKP. Synthesis and characterization of meso-ferrocenylethynyl 5,15-diphenylporphyrins. J Organom Chem. 2004;689:1593. doi: 10.1016/j.jorganchem.2004.02.007. [DOI] [Google Scholar]
  • 41.Zimmer B, Bulach V, Drexler C, Erhardt S, Hosseini MW, De Cian A. Design, synthesis, structural analysis and atropoisomerisation studies of polynucleating ligands based on porphyrins bearing catechol units. New J Chem. 2002;26:43. doi: 10.1039/b104084g. [DOI] [Google Scholar]
  • 42.Ojadi ECA, Linschitz H, Gouterman M, Walter RI, Lindsey JS, Wagner RW, Droupadi PR, Wang W. Sequential protonation of meso-[p (dimethylamino)phenyl] porphyrins: charge-transfer excited states producing hyperporphyrins. J Phy Chem. 1993;97:13192. doi: 10.1021/j100152a025. [DOI] [Google Scholar]
  • 43.Belete BB, Sandeep BM, Chen HH. Electrochemical hydrogen evolution by cobalt (II) porphyrins: effects of ligand modification on catalytic activity, efficiency and overpotential. J Electrochem Soc. 2018;165(9):H481–H487. doi: 10.1149/2.0481809jes. [DOI] [Google Scholar]
  • 44.Belete BB, Chen HH. Porphyrin-based electrochemical H2 evolution: role ofcentral metal ion on overpotential and catalytic activity. Electrocatalysis. 2018;9(6):689–696. doi: 10.1007/s12678-018-0477-z. [DOI] [Google Scholar]
  • 45.Rothemund P. Porphyrin studies. III. The structure of the porphine ring system. J Am Chem Soc. 1939;61:912. doi: 10.1021/ja01265a096. [DOI] [Google Scholar]
  • 46.Tanja S, Enisa S, Braho L. Second international electronic conference on medicinal chemistry. State University of Novi Pazar, Novi Pazar, Republic Serbia: MDPIAG; 2016. Antibacterial activity of zinc(II) and copper(II) terpyridine complexes; pp. 1–30. [Google Scholar]
  • 47.Raman N, Kulandaisamy A, Thangaraja C, Manisankar P, Viswanathan S, Vedhi C. Synthesis, structural characterisation and electrochemical and antibacterial studies of Schiff base copper complexes. Transition Met Chem. 2004;29(2):129–135. doi: 10.1023/B:TMCH.0000019409.50574.0a. [DOI] [Google Scholar]
  • 48.Tweedy BG. Plant extracts with metal ions as potential antimicrobial agents. Phytopathology. 1964;55:910–917. [Google Scholar]
  • 49.Zemede YB, Nithyakalyani D, Kumar A. Synthesis, structural characterization, corrosion inhibition and in vitro antimicrobial studies of 2-(5-methoxy-2-hydroxybenzylideneamino) phenol schiff base ligand and its transition metal complexes. Synthesis. 2014;6(11):4569–4578. [Google Scholar]
  • 50.Walther MJ, Brocker DW, Nimtz M, Rohde M, Jahn D, Moser J. Protochloro phyllide: a new photosensitizer for the photodynamic inactivation of gram-positive and gram-negative bacteria. FEMS Microbiol Lett. 2009;290:156. doi: 10.1111/j.1574-6968.2008.01413.x. [DOI] [PubMed] [Google Scholar]
  • 51.Yamamoto T, Iriuchishima T, Aizawa S, Okano T, Goto B, Nagai Y, Horaguchi T, Ryu J, Saito A. Bactericidal effect of photodynamic therapy using Na-Pheophorbide A: evaluation of adequate light source. Photomed Laser Surg. 2009;27:849. doi: 10.1089/pho.2008.2319. [DOI] [PubMed] [Google Scholar]
  • 52.Drulis-Kawa Z, Bednarkiewicz A, Bugla-Ploskonska G, Strek W, Doroszkiewicz W. The susceptibility of anaerobic bacteria isolated from periodontal diseases to photodynamic inactivation with Fotolon (chlorin e6) Pol J Microbiol. 2005;54:305. [PubMed] [Google Scholar]
  • 53.Fomichev A, Zorin VP, Zorina TE, Cherenkevich SN. Photoinduced damage of gram-positive and gram-negative bacterial cells in the presence of e6 chlorine derivatives. Mikrobiologia. 1991;60:507. [PubMed] [Google Scholar]
  • 54.Schastak S, Gitter B, Handzel R, Hermann R, Wiedemann P. Improved photoinactivation of gram-negative and gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing meso-tetrahydroporphyrin: a comparative study with a chlorine photosensitizer photolon. Methods Find Exp Clin Pharmacol. 2008;30:129. doi: 10.1358/mf.2008.30.2.1165448. [DOI] [PubMed] [Google Scholar]
  • 55.Go PM, Reed RN, Straight RC, Waner M. Laser photodynamic therapy for papilloma viral lesions. Arch Otolaryngol Head Neck Surg. 1990;116:1177. doi: 10.1001/archotol.1990.01870100071015. [DOI] [PubMed] [Google Scholar]
  • 56.Pfitzner A, Sigusch BW, Albrecht V, Glockmann E. Killing of periodontopathogenic bacteria by photodynamic therapy. J Periodontol. 2004;75:1343. doi: 10.1902/jop.2004.75.10.1343. [DOI] [PubMed] [Google Scholar]
  • 57.Sigusch BW, Pfitzner A, Albrecht V, Glockmann E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol. 2005;76:1100. doi: 10.1902/jop.2005.76.7.1100. [DOI] [PubMed] [Google Scholar]

Articles from BMC Chemistry are provided here courtesy of BMC

RESOURCES